Interestingly, Teng et al. demonstrated that one of mortalin’s oncogenic roles involves activating STAT3, which enhances the motility and invasiveness of human hepatocellular carcinoma cells [39]. This evidence concerns the gene HSPA9 and hepatocellular carcinoma.